173 related articles for article (PubMed ID: 21915610)
1. Trypsin promotes efficient influenza vaccine production in MDCK cells by interfering with the antiviral host response.
Seitz C; Isken B; Heynisch B; Rettkowski M; Frensing T; Reichl U
Appl Microbiol Biotechnol; 2012 Jan; 93(2):601-11. PubMed ID: 21915610
[TBL] [Abstract][Full Text] [Related]
2. Efficient influenza B virus propagation due to deficient interferon-induced antiviral activity in MDCK cells.
Frensing T; Seitz C; Heynisch B; Patzina C; Kochs G; Reichl U
Vaccine; 2011 Sep; 29(41):7125-9. PubMed ID: 21651940
[TBL] [Abstract][Full Text] [Related]
3. High yields of influenza A virus in Madin-Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state.
Seitz C; Frensing T; Höper D; Kochs G; Reichl U
J Gen Virol; 2010 Jul; 91(Pt 7):1754-63. PubMed ID: 20357039
[TBL] [Abstract][Full Text] [Related]
4. Development and strategies of cell-culture technology for influenza vaccine.
Feng SZ; Jiao PR; Qi WB; Fan HY; Liao M
Appl Microbiol Biotechnol; 2011 Feb; 89(4):893-902. PubMed ID: 21063703
[TBL] [Abstract][Full Text] [Related]
5. Rational design of medium supplementation strategy for improved influenza viruses production based on analyzing nutritional requirements of MDCK Cells.
Huang D; Xia-Hou K; Liu XP; Zhao L; Fan L; Ye Z; Tan WS; Luo J; Chen Z
Vaccine; 2014 Dec; 32(52):7091-7. PubMed ID: 25444832
[TBL] [Abstract][Full Text] [Related]
6. Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production.
Frensing T; Pflugmacher A; Bachmann M; Peschel B; Reichl U
Appl Microbiol Biotechnol; 2014 Nov; 98(21):8999-9008. PubMed ID: 25132064
[TBL] [Abstract][Full Text] [Related]
7. Comparison of influenza virus yields and apoptosis-induction in an adherent and a suspension MDCK cell line.
Peschel B; Frentzel S; Laske T; Genzel Y; Reichl U
Vaccine; 2013 Nov; 31(48):5693-9. PubMed ID: 24113260
[TBL] [Abstract][Full Text] [Related]
8. Differential activation of host cell signalling pathways through infection with two variants of influenza A/Puerto Rico/8/34 (H1N1) in MDCK cells.
Heynisch B; Frensing T; Heinze K; Seitz C; Genzel Y; Reichl U
Vaccine; 2010 Nov; 28(51):8210-8. PubMed ID: 20691654
[TBL] [Abstract][Full Text] [Related]
9. MDCK cell line with inducible allele B NS1 expression propagates delNS1 influenza virus to high titres.
van Wielink R; Harmsen MM; Martens DE; Peeters BP; Wijffels RH; Moormann RJ
Vaccine; 2011 Sep; 29(40):6976-85. PubMed ID: 21787829
[TBL] [Abstract][Full Text] [Related]
10. Suitability of MDCK cells grown in a serum-free medium for influenza virus production.
Kessler N; Thomas-Roche G; Gérentes L; Aymard M
Dev Biol Stand; 1999; 98():13-21; discussion 73-4. PubMed ID: 10494956
[TBL] [Abstract][Full Text] [Related]
11. Bioprocess optimization for cell culture based influenza vaccine production.
Aggarwal K; Jing F; Maranga L; Liu J
Vaccine; 2011 Apr; 29(17):3320-8. PubMed ID: 21335031
[TBL] [Abstract][Full Text] [Related]
12. Productivity, apoptosis, and infection dynamics of influenza A/PR/8 strains and A/PR/8-based reassortants.
Isken B; Genzel Y; Reichl U
Vaccine; 2012 Jul; 30(35):5253-61. PubMed ID: 22698452
[TBL] [Abstract][Full Text] [Related]
13. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process.
George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L
Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670
[TBL] [Abstract][Full Text] [Related]
14. CAP, a new human suspension cell line for influenza virus production.
Genzel Y; Behrendt I; Rödig J; Rapp E; Kueppers C; Kochanek S; Schiedner G; Reichl U
Appl Microbiol Biotechnol; 2013 Jan; 97(1):111-22. PubMed ID: 22821436
[TBL] [Abstract][Full Text] [Related]
15. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.
Hu AY; Weng TC; Tseng YF; Chen YS; Wu CH; Hsiao S; Chou AH; Chao HJ; Gu A; Wu SC; Chong P; Lee MS
Vaccine; 2008 Oct; 26(45):5736-40. PubMed ID: 18761387
[TBL] [Abstract][Full Text] [Related]
16. Production of influenza H1N1 vaccine from MDCK cells using a novel disposable packed-bed bioreactor.
Sun B; Yu X; Kong W; Sun S; Yang P; Zhu C; Zhang H; Wu Y; Chen Y; Shi Y; Zhang X; Jiang C
Appl Microbiol Biotechnol; 2013 Feb; 97(3):1063-70. PubMed ID: 22945265
[TBL] [Abstract][Full Text] [Related]
17. High yield production of influenza virus in Madin Darby canine kidney (MDCK) cells with stable knockdown of IRF7.
Hamamoto I; Takaku H; Tashiro M; Yamamoto N
PLoS One; 2013; 8(3):e59892. PubMed ID: 23555825
[TBL] [Abstract][Full Text] [Related]
18. Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines.
van Wielink R; Kant-Eenbergen HC; Harmsen MM; Martens DE; Wijffels RH; Coco-Martin JM
J Virol Methods; 2011 Jan; 171(1):53-60. PubMed ID: 20933017
[TBL] [Abstract][Full Text] [Related]
19. Use of MDCK cells for production of live attenuated influenza vaccine.
Liu J; Shi X; Schwartz R; Kemble G
Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
[TBL] [Abstract][Full Text] [Related]
20. Cloning and assessment of tumorigenicity and oncogenicity of a Madin-Darby canine kidney (MDCK) cell line for influenza vaccine production.
Liu J; Mani S; Schwartz R; Richman L; Tabor DE
Vaccine; 2010 Feb; 28(5):1285-93. PubMed ID: 19944150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
